7Baggers

Genetic Technologies Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20070331 20070630 20070930 20071231 20080331 20080630 20150630 20160630 20170630 20180630 20190630 20200630 20201231 20210630 20220630 20220930 20221231 20230331 20230630 20231231 -14.35-11.35-8.36-5.36-2.360.643.636.63Milllion

Genetic Technologies Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30 2020-12-31 2020-06-30 2019-06-30 2018-06-30 2017-06-30 2016-06-30 2015-06-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 
  revenue3,958,682 4,532,171 2,685,018 4,153,946 2,488,935 4,743,800 107,697 8,218 4,639 25,444 189,254 518,506 824,586 2,011,918 3,330,984.826 6,630,654.002 4,540,442.793 4,420,017.29 6,323,673.945 4,240,091.828 1,964,350.59 2,708,356.394 2,191,031.76 2,569,080.412 3,361,703.327 3,376,080.415 -1,033,409.693 3,551,023.366 3,510,036.439 3,763,777.643 
  cost of revenue5,939,874 5,755,582 1,093,790 5,700,351 1,073,843 1,818,439 241,009 91,513 28,505 276,267 300,088 492,417 743,060 891,243 889,451.781 813,206.731 512,765.722 1,227,940.566 
  gross profit-1,981,192 -1,223,411 1,591,228 -1,546,405 1,415,092 2,925,361 -133,312 -83,295 -23,866 -250,823 -110,834 26,089 81,526 1,120,675 3,330,984.826 6,630,654.002 3,650,991.012 4,420,017.29 6,323,673.945 4,240,091.828 1,151,143.859 2,708,356.394 2,191,031.76 2,569,080.412 2,848,937.605 3,376,080.415 -1,033,409.693 3,551,023.366 2,282,095.874 3,763,777.643 
  operating expenses                              
  research and development389,758 722,851 361,426 558,306 279,153 -1,425,472 -4,314,956 530,846 674,727 -2,360,762 -2,210,498 -2,366,334 -2,584,752 -2,851,665 289,293.39 397,271.826 333,439.752 395,869.118 
  sales, general and administrative                              
  total operating expenses3,182,164 3,359,301 4,805,084 3,845,059 4,251,186 7,239,342 -190,933 91,513 28,505 1,019,769 441,476 344,112 492,037 370,557 3,717,516.882 3,680,915.271 4,288,045.346 2,468,866.708 
  operating income-5,163,360 -4,582,710 -2,512,475 -5,391,460 -2,695,731 -4,313,980 4,064,989 -1,733,836 -2,368,621 23,668 -522,966 -130,655 1,307,219 414,005 -14,350,828.563 6,630,654.002 -66,525.87 4,420,017.29 -8,990,615.256 4,240,091.828 -2,529,771.412 2,708,356.394 -13,875,752.071 2,569,080.412 -1,439,107.741 3,376,080.415 -18,269,054.28 3,551,023.366 -186,770.834 3,763,777.643 
  net income-6,419,264 -6,290,625 -3,145,313 -5,460,298 -2,730,149 -3,249,627 -3,614,455 -1,737,548 -1,725,616 -6,425,604 -5,463,872 -8,403,826 -8,458,965 -8,810,170 -2,501,777.071 -2,501,902.577 -226,830.943 -226,918.276 1,138,964.117 1,391,208.354 -2,658,326.334 -3,556,721.055 -1,199,272.751 -1,406,198.776 -1,538,880.32 -1,538,730.778 -488,072.715 -6,508,679.232 -264,780.416 -283,921.443 

We provide you with 20 years income statements for Genetic Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Genetic Technologies stock. Explore the full financial landscape of Genetic Technologies stock with our expertly curated income statements.

The information provided in this report about Genetic Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.